Flemish biologists led by Joris Messens of the Flanders Institute for Biotechnology have discovered that Mycobacterium tuberculosis the bacterium that causes tuberculosis has an ingenious defense mechanism against oxygen. This knowledge is important in the search for a treatment for tuberculosis. As many as 9.4 million people are infected with tuberculosis annually and 1.7 million people die as a result.
Says Messens, "We have discovered how Mycobacterium survives the oxygen stress in our body, namely with the aid of the protein mycoredoxin-1. This opens up a whole new field of research into the role of this protein during a tuberculosis infection. A better understanding of this mechanism will enable us to combat this bacterium more selectively."
Oxygen is essential for the respiration of nearly all cells. They use this gas to burn sugars in order to produce energy. However, oxygen is also very aggressive and can seriously affect proteins the building blocks of the cell in a manner similar to rust or oxidation of iron.
Our immune system uses reactive oxygen molecules in the defence against intruders, for example against Mycobacterium. Proteins are particularly sensitive to the effects of oxygen (oxidation). Proteins with sulphur-containing components are particularly sensitive and become inactive with oxidation. Following damage by oxygen, Mycobacterium places the mycothiol molecule on such proteins. After a period of oxygen stress this molecule has to be removed again for the proper functioning of the protein. It was not known how this happened, until now.
Messens and his team have discovered that Mycobacterium tuberculosis protects sulphur-containing proteins in a unique way and actively repairs these proteins once the oxygen stress disappears. They discovered the protein mycoredoxin-1, which forms the basis of this ingenious repair mechanism. The scientists analysed the protein structure and the function of the protein and found that mycoredoxin-1 selectively removes mycothiol from affected sulphur-containing proteins and thereby ensures the activation of these proteins.
Messens says, "We could combat tuberculosis more effectively by searching for components that disable mycoredoxin-1. The bacterium would not be able to recover as quickly from an oxygen attack by our immune system."
From the Derby to the Decontam Room: Leadership Lessons for Sterile Processing
April 27th 2025Elizabeth (Betty) Casey, MSN, RN, CNOR, CRCST, CHL, is the SVP of Operations and Chief Nursing Officer at Surgical Solutions in Overland, Kansas. This SPD leader reframes preparation, unpredictability, and teamwork by comparing surgical services to the Kentucky Derby to reenergize sterile processing professionals and inspire systemic change.
Show, Tell, Teach: Elevating EVS Training Through Cognitive Science and Performance Coaching
April 25th 2025Training EVS workers for hygiene excellence demands more than manuals—it requires active engagement, motor skills coaching, and teach-back techniques to reduce HAIs and improve patient outcomes.
The Rise of Disposable Products in Health Care Cleaning and Linens
April 25th 2025Health care-associated infections are driving a shift toward disposable microfiber cloths, mop pads, and curtains—offering infection prevention, regulatory compliance, and operational efficiency in one-time-use solutions.
Phage Therapy’s Future: Tackling Antimicrobial Resistance With Precision Viruses
April 24th 2025Bacteriophage therapy presents a promising alternative to antibiotics, especially as antimicrobial resistance continues to increase. Dr. Ran Nir-Paz discusses its potential, challenges, and future applications in this technology.